Why it was recalled
Presence of Particulate Matter: Presence of glass particulates.
Product description
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Lot numbers, UPCs & expiration codes
Lot #SP2400058, Exp 12/31/2024
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0040-2025
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- Sep 30, 2024
- FDA report date
- Nov 13, 2024
- Quantity
- 4773 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Staska Pharmaceuticals, Inc.
Original FDA data
Every field from FDA enforcement report D-0040-2025, exactly as published.
Show all FDA fields
- City
- Bennet
- State
- NE
- Status
- Terminated
- Country
- United States
- Event ID
- 95503
- Address
- 742 Evergreen Dr
- Code information
- Lot #SP2400058, Exp 12/31/2024
- Postal code
- 68317-2365
- Report date
- Nov 13, 2024
- Product type
- Drugs
- Recall number
- D-0040-2025
- Classification
- Class I
- Recalling firm
- Staska Pharmaceuticals, Inc.
- Product quantity
- 4773 vials
- Termination date
- Aug 5, 2025
- Reason for recall
- Presence of Particulate Matter: Presence of glass particulates.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Sep 30, 2024
- Initial firm notification
- Letter
- Center classification date
- Nov 7, 2024